Heart rhythm risks in ATTR amyloidosis patients on tafamidis under scrutiny
Knowledge-focused
Recruiting now
This study follows 200 adults with ATTRwt amyloidosis who are taking tafamidis to see how often they develop heart rhythm problems that need a pacemaker or defibrillator. Researchers will also track changes in diuretic use. Participants are checked every six months as part of rou…
Sponsor: Paolo Milani • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC